Thrombocytosis
- Name
- Thrombocytosis
- Accession Number
- DBCAT000632
- Description
Not Available
- Drugs
Drug Drug Description Anagrelide A platelet-reducing agent used to treat thrombocythemia, and its related complications, secondary to myeloproliferative neoplasms. - Drugs & Drug Targets
Drug Target Type Anagrelide cGMP-inhibited 3',5'-cyclic phosphodiesterase A target Anagrelide Cytochrome P450 1A2 enzyme